We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRA icon
926
Vera Bradley
VRA
$98.7M
$411K ﹤0.01%
34,278
+20,919
+157% +$248K
HNGR
927
DELISTED
Hanger Inc.
HNGR
$411K ﹤0.01%
21,457
-59,149
-73% -$1.14M
GME icon
928
GameStop
GME
$8.6B
$410K ﹤0.01%
+299,776
New +$586K
DPLO
929
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$407K ﹤0.01%
+66,836
New +$355K
LOW icon
930
Lowe's Companies
LOW
$125B
$402K ﹤0.01%
+3,980
New +$420K
PRTA icon
931
Prothena Corp
PRTA
$450M
$401K ﹤0.01%
+37,941
New +$390K
CAG icon
932
Conagra Brands
CAG
$7.23B
$398K ﹤0.01%
15,003
-220,582
-94% -$6.41M
HMC icon
933
Honda
HMC
$41.3B
$392K ﹤0.01%
15,165
-21,146
-58% -$563K
NGL icon
934
NGL Energy Partners
NGL
$2.11B
$389K ﹤0.01%
26,325
-274,390
-91% -$3.93M
CNR
935
DELISTED
Cornerstone Building Brands, Inc.
CNR
$385K ﹤0.01%
65,911
-6,590
-9% -$36.6K
MCY icon
936
Mercury Insurance
MCY
$6.07B
$379K ﹤0.01%
6,066
+5,666
+1,417% +$316K
ELP
937
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$378K ﹤0.01%
74,448
-32,030
-30% -$142K
SRDX
938
DELISTED
Surmodics
SRDX
$374K ﹤0.01%
+8,652
New +$365K
DTIL icon
939
Precision BioSciences
DTIL
$207M
$372K ﹤0.01%
936
-808
-46% -$325K
OPLN
940
Openlane
OPLN
$4.54B
$370K ﹤0.01%
14,791
-707,228
-98% -$15.2M
PJT icon
941
PJT Partners
PJT
$4.38B
$368K ﹤0.01%
9,082
-4,166
-31% -$170K
NCNA
942
NuCana
NCNA
$6.12M
$367K ﹤0.01%
7
-5
-42% -$343K
PAGS icon
943
PagSeguro Digital
PAGS
$2.55B
$364K ﹤0.01%
9,341
+3,312
+55% +$103K
MSGN
944
DELISTED
MSG Networks Inc.
MSGN
$360K ﹤0.01%
17,333
+16,533
+2,067% +$363K
LFUS icon
945
Littelfuse
LFUS
$11.6B
$358K ﹤0.01%
+2,026
New +$368K
NNN icon
946
NNN REIT
NNN
$8.99B
$358K ﹤0.01%
+6,740
New +$360K
CMCO icon
947
Columbus McKinnon
CMCO
$584M
$356K ﹤0.01%
8,497
+3,952
+87% +$150K
YPF icon
948
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
$353K ﹤0.01%
19,378
-83,528
-81% -$1.29M
CDK
949
DELISTED
CDK Global, Inc.
CDK
$353K ﹤0.01%
+7,135
New +$382K
ZWS icon
950
Zurn Elkay Water Solutions
ZWS
$8.53B
$352K ﹤0.01%
24,185
+17,681
+272% +$238K
36 37
38
39 40

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.